4//SEC Filing
Miller Aine 4
Accession 0001415889-24-022088
CIK 0001583107other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 8:06 PM ET
Size
4.9 KB
Accession
0001415889-24-022088
Insider Transaction Report
Form 4
Miller Aine
SVP, DEV & HEAD OF IRE OFFICE
Transactions
- Tax Payment
Ordinary Shares
2024-08-20$8.22/sh−5,201$42,752→ 160,632 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0002012524
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 8:06 PM ET
- Size
- 4.9 KB